Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
October 27, 2011
Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
B Melichar, E Casado, J Bridgewater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
D Basile, C Broudin, J F Emile, et al.
Respiratory Medicine and Research
|
June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemic
N Girard, L Greillier, G Zalcman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
G Robinet, P Thomas, J L Breton, et al.
Cancer Immunology, Immunotherapy : CII
|
January 23, 2023
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50
E Pons-Tostivint, P Hulo, V Guardiolle, et al.
Cancer Immunology, Immunotherapy : CII
|
February 27, 2023
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50
E Pons-Tostivint, P Hulo, V Guardiolle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2015
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
J Vansteenkiste, F Barlesi, C F Waller, et al.
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal
P A Ott, S A Piha-Paul, P Munster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
F Pagès, T André, J Taieb, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
October 27, 2011
Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
B Melichar, E Casado, J Bridgewater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2022
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
D Basile, C Broudin, J F Emile, et al.
Respiratory Medicine and Research
|
June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemic
N Girard, L Greillier, G Zalcman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
G Robinet, P Thomas, J L Breton, et al.
Cancer Immunology, Immunotherapy : CII
|
January 23, 2023
Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50
E Pons-Tostivint, P Hulo, V Guardiolle, et al.
Cancer Immunology, Immunotherapy : CII
|
February 27, 2023
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50
E Pons-Tostivint, P Hulo, V Guardiolle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 6, 2015
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
J Vansteenkiste, F Barlesi, C F Waller, et al.
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal
P A Ott, S A Piha-Paul, P Munster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
F Pagès, T André, J Taieb, et al.
Page
of 6